drugset / Trial / NCT03673605
Efficacy and Safety of Rivaroxiban Compare With Vitamin K Antagonist Warfarin
RandomizedParallel-groupOpen-labelTreatment
Summary
Title: Efficacy and safety of rivaroxiban compare with vitamin K antagonist warfarin in patients with atrial fibrillation and mitral stenosis among Pakistani population.
Timeline
- Start
- 2016-12-30
- Primary completion
- 2017-10-30
- Completion
- 2017-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rivaroxaban | Other / unclassified | 15 mg | Oral |
| Comparator | Warfarin | Small molecule | — | — |